Document is current
Any future updates will be listed below
-
Authors
Juckett, William T.
Evanoff, Nicholas G.
Kelly, Aaron S.
Bomberg, Eric M.
Dengel, Donald R.
-
Funding
Funding for this research was provided by:
National Heart, Lung, And Blood Institute of the National Institutes of Health (R01HL110957)
National Institute of Diabetes, And Digestive, And Kidney Diseases (NIDDK) of the National Institutes of Health (K23 DK125668)
- License Information
-
More Information
Article History
Received: 1 May 2025
Accepted: 4 June 2025
First Online: 10 July 2025
Declarations
:
: Dr. Kelly engages in unpaid consulting and educational activities, as well as serves as an unpaid investigator for Novo Nordisk; engages in unpaid consulting activities and serves as an unpaid investigator for Boehringer Ingelheim, Eli Lilly, and Vivus; receives donated drug/placebo from Novo Nordisk and Vivus for National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)-funded clinical trials. Dr. Bomberg has served as a site principal investigator and site co-investigator for Novo Nordisk. All other authors (W.T.J., N.G.E., D.R.D.) have nothing to declare.
